Check out the companies making headlines before the bell. Nvidia \u2014 Shares dipped 2%, adding to losses from Thursday, when Nvidia closed down 3.5%. The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most valuable public company. Sarepta Therapeutics \u2014 The biopharma stock soared 37% after the U.S. Food and Drug Administration granted approval for an expanded use of Sarepta’s Elevidys gene therapy , which would treat patients with Duchenne muscular dystrophy. The therapy was traditionally approved for all patients 4 years or older who are able to walk, with accelerated approval given for those who cannot walk. Nike \u2014 The athletic clothing maker moved 1% higher following an upgrade at Oppenheimer to outperform from market perform. The firm also reinstated Nike as a top megacap pick, saying that the stock is poised to rebound gradually as the company refocuses on product innovation and brand-building. Asana \u2014 Shares popped more than 3% after the software firm announced a $150 million share buyback plan. The company expects its stock repurchase program to continue through June 30, 2025. Gilead Sciences \u2014 The pharmaceutical stock rose more than 2.6%, building on a rally of 8.5% from the previous session. On Thursday, Gilead announced that an HIV-prevention shot succeeded in a late-stage trial . LendingTree \u2014 Shares of the online lending marketplace were marginally lower after Bloomberg reported that hackers are now auctioning off stolen data from the site. LendingTree was the victim of a cyberattack against cloud computing firm Snowflake. Apple \u2014 Stock in the iPhone maker ticked up following a price increase from Bernstein. Analyst Toni Sacconaghi asserted that the more bullish outlook is tied to his view that Apple can emerge as a leader of the artificial intelligence boom, “not a laggard.” Delta Air Lines \u2014 The stock rose 0.7% following news Thursday that the airliner announced a quarterly dividend of 15 cents a share, a 50% increase from previous levels. \u2014 CNBC’s Brian Evans, Michelle Fox, Jesse Pound and Sarah Min contributed reporting.<\/span><\/span><\/span><\/span><\/p>\n<\/div>\n<\/div>\n Source: www.cnbc.com<\/p>\n","protected":false},"excerpt":{"rendered":" Check out the companies making headlines before the bell. Nvidia \u2014 Shares dipped 2%, adding to losses from Thursday, when Nvidia closed down 3.5%. The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most valuable public company. Sarepta Therapeutics \u2014 The biopharma stock soared 37% after the U.S. Food and…<\/p>\n","protected":false},"author":1,"featured_media":80841,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","om_disable_all_campaigns":false,"WB4WB4WP_MODE":"","WB4WP_PAGE_SCRIPTS":"","WB4WP_PAGE_STYLES":"","WB4WP_PAGE_FONTS":"","WB4WP_PAGE_HEADER":"","WB4WP_PAGE_FOOTER":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[78],"tags":[],"class_list":["post-80840","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"\n